Avient has the portfolio and material science expertise to help customers deliver value and innovation and meet the increasing demands of renewable energy applications.  The Solution & Impact Avient Protective Materials worked with offshore wind farms to develop low pre-tension mooring systems made from Dyneema® DM20. Avient Protective Materials worked with offshore wind farms to develop low pre-tension mooring systems made from Dyneema® DM20.

Avient Investor Relations Avient Company Officers See how Avient opens up possibilities for the world through plastics

Avient Announces Quarterly Dividend... Avient Board of Directors Appoints Ashish K. Avient Announces First Quarter 2025 Results...

Contact Avient to learn more. Overview: Avient Advanced Composites A guide to Avient’s ballistic panel solutions, their properties, and applications

Whether you’re designing an MRI machine or a handheld imaging device, Avient polymer materials will help you deliver equipment that’s functional, protective, and compliant. Avient Design Sync design with manufacturability: Learn about how Avient Design can help simplify your new product development process

Home // Sustainability // Sustainability at Avient // Reporting // CDP Climate Change Report

We've interviewed Chris Lefteri, Marshall Hamachi, and Owen Foster to glean their insights on materials-centric design, plus rounded up some success stories from the Avient Design team to illustrate how this concept plays out in the real world. 

Avient’s reinforced composite technologies use carbon, glass and aramid fibers with custom formulated thermoset or thermoplastic resins in continuous forming processes Avient Design Sync design with manufacturability: Learn about how Avient Design can help simplify your new product development process

Avient’s wide range of medical-grade polymer compounds, colorants, and functional additives can help mitigate risk, streamline your path to market, and deliver desired patient outcomes. With Avient materials, you can create compliant devices that doctors and patients prefer.

Avient reported organic revenue growth for the fourth consecutive quarter and expanded adjusted EBITDA margins 20 bps to 17.5%.   Avient’s chief operating decision-maker uses these financial measures to monitor and evaluate the ongoing performance of the Company and each business segment and to allocate resources.